|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,223.85 INR | -1.75% |
|
+0.86% | +9.23% |
| 07-07 | India finds Adani's Mumbai airport shops sold nicotine pouches in breach of law | RE |
| 07-06 | Glenmark Pharmaceuticals Launches Olanzapine for Injection | MT |
| Market Cap | 639B 6.73B 5.89B 5.43B 5.03B 9.56B 9.71B 65.13B 25.33B 315B 25.28B 24.74B 1,090B | P/E 2026 |
44.2x | P/E 2027 * | 27.3x |
|---|---|---|---|---|---|
| Enterprise Value | 600B 6.32B 5.53B 5.1B 4.72B 8.97B 9.11B 61.12B 23.77B 296B 23.73B 23.21B 1,023B | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.61x |
| Free-Float |
51.03% | Yield 2026 |
0.12% | Yield 2027 * | 0.24% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | -1.75% | ||
| 1 week | +0.86% | ||
| Current month | +0.86% | ||
| 1 month | +2.08% | ||
| 3 months | +5.23% | ||
| 6 months | +5.24% | ||
| Current year | +9.23% |
| 1 week | 2,146.55 |  | 2,299.05 |
| 1 month | 2,109 | | 2,299.05 |
| Current year | 1,842.8 | | 2,471.05 |
| 1 year | 1,793.5 | | 2,471.05 |
| 3 years | 661 | | 2,471.05 |
| 5 years | 348.9 | | 2,471.05 |
| 10 years | 168 | | 2,471.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 85 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.75% | +0.86% | - | - | 6.73B | |
| -0.84% | +1.41% | +12.44% | +82.37% | 48.12B | |
| -3.08% | +3.29% | +65.80% | +113.96% | 37.36B | |
| -1.41% | -2.33% | -5.24% | +40.23% | 12.36B | |
| -0.39% | +3.36% | +15.14% | +97.51% | 12.12B | |
| +0.96% | +2.76% | +34.19% | +120.25% | 9.14B | |
| -3.18% | -1.08% | +18.73% | +43.61% | 7.21B | |
| +1.24% | +4.23% | +58.03% | -1.50% | 7.14B | |
| -2.81% | +17.66% | -18.38% | +20.93% | 6.35B | |
| -0.94% | -4.05% | +23.59% | +131.07% | 4.36B | |
| Average | -1.17% | +3.39% | +22.70% | +72.05% | 16.02B | |
| Weighted average by Cap. | -1.39% | +3.66% | +27.91% | +83.30% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 153B 1.61B 1.41B 1.3B 1.21B 2.29B 2.33B 15.6B 6.07B 75.56B 6.06B 5.93B 261B | 167B 1.76B 1.54B 1.42B 1.31B 2.5B 2.54B 17.01B 6.61B 82.37B 6.6B 6.46B 285B |
| Net income | 20.53B 216M 189M 174M 162M 307M 312M 2.09B 814M 10.13B 812M 795M 35.02B | 23.22B 245M 214M 197M 183M 347M 353M 2.37B 920M 11.46B 919M 899M 39.61B |
| Net Debt | -39.29B -414M -362M -334M -309M -588M -597M -4B -1.56B -19.39B -1.55B -1.52B -67.03B | -37.12B -391M -342M -315M -292M -555M -564M -3.78B -1.47B -18.32B -1.47B -1.44B -63.32B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/07/26 | ₹2,223.85 | -1.75% | 10,353 |
| 07/07/26 | ₹2,263.45 | -0.31% | 17,397 |
| 06/07/26 | ₹2,270.45 | +2.74% | 30,046 |
| 03/07/26 | ₹2,209.85 | +0.68% | 16,784 |
| 02/07/26 | ₹2,195.00 | +1.73% | 21,175 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
- GLENMARK Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
